Oing, ChristophChristophOingGiannatempo, PatriziaPatriziaGiannatempoHonecker, FriedemannFriedemannHoneckerOechsle, KarinKarinOechsleBokemeyer, CarstenCarstenBokemeyerBeyer, JörgJörgBeyer2024-10-072024-10-072018-12https://boris-portal.unibe.ch/handle/20.500.12422/63009Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.enDrug therapy Germ cell cancer Germ cell tumor Palliative treatment Platinum-refractory600 - Technology::610 - Medicine & healtharticle10.7892/boris.1249313041510610.1016/j.ctrv.2018.10.007